QTTB
Price
$3.37
Change
-$0.22 (-6.13%)
Updated
Dec 23, 11:58 AM (EDT)
STOK
Price
$11.49
Change
-$0.19 (-1.63%)
Updated
Dec 23, 12:17 PM (EDT)
72 days until earnings call
Ad is loading...

QTTB vs STOK

Header iconQTTB vs STOK Comparison
Open Charts QTTB vs STOKBanner chart's image
Q32 Bio
Price$3.37
Change-$0.22 (-6.13%)
Volume$500
CapitalizationN/A
Stoke Therapeutics
Price$11.49
Change-$0.19 (-1.63%)
Volume$333
CapitalizationN/A
QTTB vs STOK Comparison Chart
Loading...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QTTB vs. STOK commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTTB is a Hold and STOK is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (QTTB: $3.59 vs. STOK: $11.68)
Brand notoriety: QTTB and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QTTB: 245% vs. STOK: 222%
Market capitalization -- QTTB: $43.12M vs. STOK: $618.65M
QTTB [@Biotechnology] is valued at $43.12M. STOK’s [@Biotechnology] market capitalization is $618.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QTTB’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • QTTB’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, STOK is a better buy in the long-term than QTTB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QTTB’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 3 bullish TA indicator(s).

  • QTTB’s TA Score: 4 bullish, 3 bearish.
  • STOK’s TA Score: 3 bullish, 8 bearish.
According to our system of comparison, QTTB is a better buy in the short-term than STOK.

Price Growth

QTTB (@Biotechnology) experienced а -2.97% price change this week, while STOK (@Biotechnology) price change was -3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

QTTB is expected to report earnings on May 13, 2024.

STOK is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($619M) has a higher market cap than QTTB($43.1M). QTTB YTD gains are higher at: 490.461 vs. STOK (122.053). STOK has more cash in the bank: 239M vs. QTTB (89.1M). STOK has less debt than QTTB: STOK (2.3M) vs QTTB (19.4M).
QTTBSTOKQTTB / STOK
Capitalization43.1M619M7%
EBITDAN/A-115.03M-
Gain YTD490.461122.053402%
P/E RatioN/AN/A-
RevenueN/A16.7M-
Total Cash89.1M239M37%
Total Debt19.4M2.3M844%
FUNDAMENTALS RATINGS
QTTB: Fundamental Ratings
QTTB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
QTTBSTOK
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLXSX16.060.17
+1.04%
Fidelity Flex Small Cap Index
DNINX18.510.04
+0.22%
Dunham International Stock N
FERGX13.630.01
+0.07%
Fidelity SAI Emerging Markets Index
DURIX12.87-0.05
-0.39%
DWS ESG International Core Eq Instl
CRLVX9.40-0.57
-5.72%
Catholic Rspnsbl Invstmnts Intl Eq Inv

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with MESO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then MESO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
+7.49%
MESO - QTTB
52%
Loosely correlated
-12.71%
STOK - QTTB
44%
Loosely correlated
+3.36%
CLRB - QTTB
40%
Loosely correlated
-1.26%
ENTA - QTTB
35%
Loosely correlated
+7.17%
IMNN - QTTB
27%
Poorly correlated
-2.83%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+3.36%
NUVB - STOK
51%
Loosely correlated
-0.37%
STRO - STOK
48%
Loosely correlated
+3.30%
INZY - STOK
46%
Loosely correlated
+6.41%
QTTB - STOK
44%
Loosely correlated
+7.49%
DNLI - STOK
43%
Loosely correlated
-0.19%
More